Compounds of the Formulawherein A, B, C, D, X, Y, Z, R1, R2, R2′, R3 and n are described herein, selectively negatively modulate NMDA receptors containing an NR2A subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.